Cancer incidence and mortality in China, 2022Bingfeng Han, Jie He, Rongshou Zheng et al.|Journal of the National Cancer Center|2024Cited by 2k
Global, regional, and national lifetime risks of developing and dying from gastrointestinal cancers in 185 countries: a population-based systematic analysis of GLOBOCANShaoming Wang, Jie He, Wenqiang Wei et al.|The Lancet. Gastroenterology & hepatology|2024Cited by 248
Global landscape and trends in lifetime risks of haematologic malignancies in 185 countries: population-based estimates from GLOBOCAN 2022Kexin Sun, Wenqiang Wei, Hongliang Wu et al.|EClinicalMedicine|2025Cited by 24
Geographic, sex and socioeconomic disparities in esophageal cancer incidence in China: A population‐based studyXianhui Ran, Jie He, Hongmei Zeng et al.|International Journal of Cancer|2023Cited by 13
Lifetime probabilities of developing and dying from cancer in China: comparison with Japan and the United States in 2022Qian Zhu, Wenqiang Wei, Yifei Yao et al.|Science China Life Sciences|2025Cited by 8